cosinor analysis in Search Results


cosinor analysis and graphs  (Wolfram Research)
90
Wolfram Research cosinor analysis and graphs
Cosinor Analysis And Graphs, supplied by Wolfram Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cosinor analysis and graphs/product/Wolfram Research
Average 90 stars, based on 1 article reviews
cosinor analysis and graphs - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
cosinor analysis  (GraphPad Software Inc)
90
GraphPad Software Inc cosinor analysis
Cosinor Analysis, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cosinor analysis/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
cosinor analysis - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
cosinor fitting analysis molcan 2019 bio rxiv  (Molcan Corporation)
90
Molcan Corporation cosinor fitting analysis molcan 2019 bio rxiv
Cosinor Fitting Analysis Molcan 2019 Bio Rxiv, supplied by Molcan Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cosinor fitting analysis molcan 2019 bio rxiv/product/Molcan Corporation
Average 90 stars, based on 1 article reviews
cosinor fitting analysis molcan 2019 bio rxiv - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
mixed-effects cosinor analysis  (SAS institute)
90
SAS institute mixed-effects cosinor analysis
(A) Healthy human subjects were studied in-laboratory and subjected to 3 days of a simulated day shift schedule ( B , control condition) or a simulated night shift condition ( C , experimental condition). This was followed by a 24-hour constant routine protocol during which blood was drawn at 3-hour intervals (ZT2, ZT5, etc.) Blood samples collected at ZT2 and ZT14 (8 AM and 8 PM, respectively, in the day shift condition, or 8 PM and 8 AM in the night shift condition) were immediately treated with 10 μM cisplatin. Blood samples were incubated and fractions were collected between 2 and 24 hours later to isolate PBMCs. Genomic DNA was purified and probed for cisplatin-DNA adduct levels with an α-Pt-(GpG) antibody using a slot-blot assay. (D) mRNA was isolated from the blood samples and gene expression for XPA, the rate-limiting factor in NER, was analyzed using the NanoString multiplex assay. (E) DNA-protein interaction between the Bmal1 and XPA is shown in the first 3,000 base pair promoter region of human melanoma SKMEL-27 cells using a ChIP assay. PER2 is a circadian clock positive control. Input and IgG are experimental positive and negative controls, respectively. (F) Quantitation of Bmal1 binding to promoter regions of PER2 and XPA from ChIP assay, indicating regions of significance after IgG binding subtraction. Statistical analysis was done using two-way ANOVA with n=3 subjects per group (B-C) and <t>cosinor</t> analysis with n=7 subjects per group (D), and t test with n=3 replicates for E-F. * =p<0.05 for circadian rhythmicity or ChIP binding. Error bars = S.E.M.
Mixed Effects Cosinor Analysis, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mixed-effects cosinor analysis/product/SAS institute
Average 90 stars, based on 1 article reviews
mixed-effects cosinor analysis - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
periodogram cosinor analysis  (Actimetrics Inc)
90
Actimetrics Inc periodogram cosinor analysis
(A) Healthy human subjects were studied in-laboratory and subjected to 3 days of a simulated day shift schedule ( B , control condition) or a simulated night shift condition ( C , experimental condition). This was followed by a 24-hour constant routine protocol during which blood was drawn at 3-hour intervals (ZT2, ZT5, etc.) Blood samples collected at ZT2 and ZT14 (8 AM and 8 PM, respectively, in the day shift condition, or 8 PM and 8 AM in the night shift condition) were immediately treated with 10 μM cisplatin. Blood samples were incubated and fractions were collected between 2 and 24 hours later to isolate PBMCs. Genomic DNA was purified and probed for cisplatin-DNA adduct levels with an α-Pt-(GpG) antibody using a slot-blot assay. (D) mRNA was isolated from the blood samples and gene expression for XPA, the rate-limiting factor in NER, was analyzed using the NanoString multiplex assay. (E) DNA-protein interaction between the Bmal1 and XPA is shown in the first 3,000 base pair promoter region of human melanoma SKMEL-27 cells using a ChIP assay. PER2 is a circadian clock positive control. Input and IgG are experimental positive and negative controls, respectively. (F) Quantitation of Bmal1 binding to promoter regions of PER2 and XPA from ChIP assay, indicating regions of significance after IgG binding subtraction. Statistical analysis was done using two-way ANOVA with n=3 subjects per group (B-C) and <t>cosinor</t> analysis with n=7 subjects per group (D), and t test with n=3 replicates for E-F. * =p<0.05 for circadian rhythmicity or ChIP binding. Error bars = S.E.M.
Periodogram Cosinor Analysis, supplied by Actimetrics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/periodogram cosinor analysis/product/Actimetrics Inc
Average 90 stars, based on 1 article reviews
periodogram cosinor analysis - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
single cosinor analysis software  (Stockgrand Ltd)
90
Stockgrand Ltd single cosinor analysis software
(A) Healthy human subjects were studied in-laboratory and subjected to 3 days of a simulated day shift schedule ( B , control condition) or a simulated night shift condition ( C , experimental condition). This was followed by a 24-hour constant routine protocol during which blood was drawn at 3-hour intervals (ZT2, ZT5, etc.) Blood samples collected at ZT2 and ZT14 (8 AM and 8 PM, respectively, in the day shift condition, or 8 PM and 8 AM in the night shift condition) were immediately treated with 10 μM cisplatin. Blood samples were incubated and fractions were collected between 2 and 24 hours later to isolate PBMCs. Genomic DNA was purified and probed for cisplatin-DNA adduct levels with an α-Pt-(GpG) antibody using a slot-blot assay. (D) mRNA was isolated from the blood samples and gene expression for XPA, the rate-limiting factor in NER, was analyzed using the NanoString multiplex assay. (E) DNA-protein interaction between the Bmal1 and XPA is shown in the first 3,000 base pair promoter region of human melanoma SKMEL-27 cells using a ChIP assay. PER2 is a circadian clock positive control. Input and IgG are experimental positive and negative controls, respectively. (F) Quantitation of Bmal1 binding to promoter regions of PER2 and XPA from ChIP assay, indicating regions of significance after IgG binding subtraction. Statistical analysis was done using two-way ANOVA with n=3 subjects per group (B-C) and <t>cosinor</t> analysis with n=7 subjects per group (D), and t test with n=3 replicates for E-F. * =p<0.05 for circadian rhythmicity or ChIP binding. Error bars = S.E.M.
Single Cosinor Analysis Software, supplied by Stockgrand Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/single cosinor analysis software/product/Stockgrand Ltd
Average 90 stars, based on 1 article reviews
single cosinor analysis software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
cosinor analysis csr software program  (Panlab)
90
Panlab cosinor analysis csr software program
(A) Healthy human subjects were studied in-laboratory and subjected to 3 days of a simulated day shift schedule ( B , control condition) or a simulated night shift condition ( C , experimental condition). This was followed by a 24-hour constant routine protocol during which blood was drawn at 3-hour intervals (ZT2, ZT5, etc.) Blood samples collected at ZT2 and ZT14 (8 AM and 8 PM, respectively, in the day shift condition, or 8 PM and 8 AM in the night shift condition) were immediately treated with 10 μM cisplatin. Blood samples were incubated and fractions were collected between 2 and 24 hours later to isolate PBMCs. Genomic DNA was purified and probed for cisplatin-DNA adduct levels with an α-Pt-(GpG) antibody using a slot-blot assay. (D) mRNA was isolated from the blood samples and gene expression for XPA, the rate-limiting factor in NER, was analyzed using the NanoString multiplex assay. (E) DNA-protein interaction between the Bmal1 and XPA is shown in the first 3,000 base pair promoter region of human melanoma SKMEL-27 cells using a ChIP assay. PER2 is a circadian clock positive control. Input and IgG are experimental positive and negative controls, respectively. (F) Quantitation of Bmal1 binding to promoter regions of PER2 and XPA from ChIP assay, indicating regions of significance after IgG binding subtraction. Statistical analysis was done using two-way ANOVA with n=3 subjects per group (B-C) and <t>cosinor</t> analysis with n=7 subjects per group (D), and t test with n=3 replicates for E-F. * =p<0.05 for circadian rhythmicity or ChIP binding. Error bars = S.E.M.
Cosinor Analysis Csr Software Program, supplied by Panlab, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cosinor analysis csr software program/product/Panlab
Average 90 stars, based on 1 article reviews
cosinor analysis csr software program - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
cosinor analysis and two-way anova  (GraphPad Software Inc)
90
GraphPad Software Inc cosinor analysis and two-way anova
(A) Healthy human subjects were studied in-laboratory and subjected to 3 days of a simulated day shift schedule ( B , control condition) or a simulated night shift condition ( C , experimental condition). This was followed by a 24-hour constant routine protocol during which blood was drawn at 3-hour intervals (ZT2, ZT5, etc.) Blood samples collected at ZT2 and ZT14 (8 AM and 8 PM, respectively, in the day shift condition, or 8 PM and 8 AM in the night shift condition) were immediately treated with 10 μM cisplatin. Blood samples were incubated and fractions were collected between 2 and 24 hours later to isolate PBMCs. Genomic DNA was purified and probed for cisplatin-DNA adduct levels with an α-Pt-(GpG) antibody using a slot-blot assay. (D) mRNA was isolated from the blood samples and gene expression for XPA, the rate-limiting factor in NER, was analyzed using the NanoString multiplex assay. (E) DNA-protein interaction between the Bmal1 and XPA is shown in the first 3,000 base pair promoter region of human melanoma SKMEL-27 cells using a ChIP assay. PER2 is a circadian clock positive control. Input and IgG are experimental positive and negative controls, respectively. (F) Quantitation of Bmal1 binding to promoter regions of PER2 and XPA from ChIP assay, indicating regions of significance after IgG binding subtraction. Statistical analysis was done using two-way ANOVA with n=3 subjects per group (B-C) and <t>cosinor</t> analysis with n=7 subjects per group (D), and t test with n=3 replicates for E-F. * =p<0.05 for circadian rhythmicity or ChIP binding. Error bars = S.E.M.
Cosinor Analysis And Two Way Anova, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cosinor analysis and two-way anova/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
cosinor analysis and two-way anova - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
cosinor analysis  (HULINKS Inc)
90
HULINKS Inc cosinor analysis
(A) Healthy human subjects were studied in-laboratory and subjected to 3 days of a simulated day shift schedule ( B , control condition) or a simulated night shift condition ( C , experimental condition). This was followed by a 24-hour constant routine protocol during which blood was drawn at 3-hour intervals (ZT2, ZT5, etc.) Blood samples collected at ZT2 and ZT14 (8 AM and 8 PM, respectively, in the day shift condition, or 8 PM and 8 AM in the night shift condition) were immediately treated with 10 μM cisplatin. Blood samples were incubated and fractions were collected between 2 and 24 hours later to isolate PBMCs. Genomic DNA was purified and probed for cisplatin-DNA adduct levels with an α-Pt-(GpG) antibody using a slot-blot assay. (D) mRNA was isolated from the blood samples and gene expression for XPA, the rate-limiting factor in NER, was analyzed using the NanoString multiplex assay. (E) DNA-protein interaction between the Bmal1 and XPA is shown in the first 3,000 base pair promoter region of human melanoma SKMEL-27 cells using a ChIP assay. PER2 is a circadian clock positive control. Input and IgG are experimental positive and negative controls, respectively. (F) Quantitation of Bmal1 binding to promoter regions of PER2 and XPA from ChIP assay, indicating regions of significance after IgG binding subtraction. Statistical analysis was done using two-way ANOVA with n=3 subjects per group (B-C) and <t>cosinor</t> analysis with n=7 subjects per group (D), and t test with n=3 replicates for E-F. * =p<0.05 for circadian rhythmicity or ChIP binding. Error bars = S.E.M.
Cosinor Analysis, supplied by HULINKS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cosinor analysis/product/HULINKS Inc
Average 90 stars, based on 1 article reviews
cosinor analysis - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
multioscillator cosinor analysis program cosifitò  (Circesoft Inc)
90
Circesoft Inc multioscillator cosinor analysis program cosifitò
(A) Healthy human subjects were studied in-laboratory and subjected to 3 days of a simulated day shift schedule ( B , control condition) or a simulated night shift condition ( C , experimental condition). This was followed by a 24-hour constant routine protocol during which blood was drawn at 3-hour intervals (ZT2, ZT5, etc.) Blood samples collected at ZT2 and ZT14 (8 AM and 8 PM, respectively, in the day shift condition, or 8 PM and 8 AM in the night shift condition) were immediately treated with 10 μM cisplatin. Blood samples were incubated and fractions were collected between 2 and 24 hours later to isolate PBMCs. Genomic DNA was purified and probed for cisplatin-DNA adduct levels with an α-Pt-(GpG) antibody using a slot-blot assay. (D) mRNA was isolated from the blood samples and gene expression for XPA, the rate-limiting factor in NER, was analyzed using the NanoString multiplex assay. (E) DNA-protein interaction between the Bmal1 and XPA is shown in the first 3,000 base pair promoter region of human melanoma SKMEL-27 cells using a ChIP assay. PER2 is a circadian clock positive control. Input and IgG are experimental positive and negative controls, respectively. (F) Quantitation of Bmal1 binding to promoter regions of PER2 and XPA from ChIP assay, indicating regions of significance after IgG binding subtraction. Statistical analysis was done using two-way ANOVA with n=3 subjects per group (B-C) and <t>cosinor</t> analysis with n=7 subjects per group (D), and t test with n=3 replicates for E-F. * =p<0.05 for circadian rhythmicity or ChIP binding. Error bars = S.E.M.
Multioscillator Cosinor Analysis Program Cosifitò, supplied by Circesoft Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/multioscillator cosinor analysis program cosifitò/product/Circesoft Inc
Average 90 stars, based on 1 article reviews
multioscillator cosinor analysis program cosifitò - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
cosinor analysis  (Adis International Limited)
90
Adis International Limited cosinor analysis
(A) Healthy human subjects were studied in-laboratory and subjected to 3 days of a simulated day shift schedule ( B , control condition) or a simulated night shift condition ( C , experimental condition). This was followed by a 24-hour constant routine protocol during which blood was drawn at 3-hour intervals (ZT2, ZT5, etc.) Blood samples collected at ZT2 and ZT14 (8 AM and 8 PM, respectively, in the day shift condition, or 8 PM and 8 AM in the night shift condition) were immediately treated with 10 μM cisplatin. Blood samples were incubated and fractions were collected between 2 and 24 hours later to isolate PBMCs. Genomic DNA was purified and probed for cisplatin-DNA adduct levels with an α-Pt-(GpG) antibody using a slot-blot assay. (D) mRNA was isolated from the blood samples and gene expression for XPA, the rate-limiting factor in NER, was analyzed using the NanoString multiplex assay. (E) DNA-protein interaction between the Bmal1 and XPA is shown in the first 3,000 base pair promoter region of human melanoma SKMEL-27 cells using a ChIP assay. PER2 is a circadian clock positive control. Input and IgG are experimental positive and negative controls, respectively. (F) Quantitation of Bmal1 binding to promoter regions of PER2 and XPA from ChIP assay, indicating regions of significance after IgG binding subtraction. Statistical analysis was done using two-way ANOVA with n=3 subjects per group (B-C) and <t>cosinor</t> analysis with n=7 subjects per group (D), and t test with n=3 replicates for E-F. * =p<0.05 for circadian rhythmicity or ChIP binding. Error bars = S.E.M.
Cosinor Analysis, supplied by Adis International Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cosinor analysis/product/Adis International Limited
Average 90 stars, based on 1 article reviews
cosinor analysis - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
cosinor analysis  (Wolters Kluwer Health)
90
Wolters Kluwer Health cosinor analysis
(A) Healthy human subjects were studied in-laboratory and subjected to 3 days of a simulated day shift schedule ( B , control condition) or a simulated night shift condition ( C , experimental condition). This was followed by a 24-hour constant routine protocol during which blood was drawn at 3-hour intervals (ZT2, ZT5, etc.) Blood samples collected at ZT2 and ZT14 (8 AM and 8 PM, respectively, in the day shift condition, or 8 PM and 8 AM in the night shift condition) were immediately treated with 10 μM cisplatin. Blood samples were incubated and fractions were collected between 2 and 24 hours later to isolate PBMCs. Genomic DNA was purified and probed for cisplatin-DNA adduct levels with an α-Pt-(GpG) antibody using a slot-blot assay. (D) mRNA was isolated from the blood samples and gene expression for XPA, the rate-limiting factor in NER, was analyzed using the NanoString multiplex assay. (E) DNA-protein interaction between the Bmal1 and XPA is shown in the first 3,000 base pair promoter region of human melanoma SKMEL-27 cells using a ChIP assay. PER2 is a circadian clock positive control. Input and IgG are experimental positive and negative controls, respectively. (F) Quantitation of Bmal1 binding to promoter regions of PER2 and XPA from ChIP assay, indicating regions of significance after IgG binding subtraction. Statistical analysis was done using two-way ANOVA with n=3 subjects per group (B-C) and <t>cosinor</t> analysis with n=7 subjects per group (D), and t test with n=3 replicates for E-F. * =p<0.05 for circadian rhythmicity or ChIP binding. Error bars = S.E.M.
Cosinor Analysis, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cosinor analysis/product/Wolters Kluwer Health
Average 90 stars, based on 1 article reviews
cosinor analysis - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


(A) Healthy human subjects were studied in-laboratory and subjected to 3 days of a simulated day shift schedule ( B , control condition) or a simulated night shift condition ( C , experimental condition). This was followed by a 24-hour constant routine protocol during which blood was drawn at 3-hour intervals (ZT2, ZT5, etc.) Blood samples collected at ZT2 and ZT14 (8 AM and 8 PM, respectively, in the day shift condition, or 8 PM and 8 AM in the night shift condition) were immediately treated with 10 μM cisplatin. Blood samples were incubated and fractions were collected between 2 and 24 hours later to isolate PBMCs. Genomic DNA was purified and probed for cisplatin-DNA adduct levels with an α-Pt-(GpG) antibody using a slot-blot assay. (D) mRNA was isolated from the blood samples and gene expression for XPA, the rate-limiting factor in NER, was analyzed using the NanoString multiplex assay. (E) DNA-protein interaction between the Bmal1 and XPA is shown in the first 3,000 base pair promoter region of human melanoma SKMEL-27 cells using a ChIP assay. PER2 is a circadian clock positive control. Input and IgG are experimental positive and negative controls, respectively. (F) Quantitation of Bmal1 binding to promoter regions of PER2 and XPA from ChIP assay, indicating regions of significance after IgG binding subtraction. Statistical analysis was done using two-way ANOVA with n=3 subjects per group (B-C) and cosinor analysis with n=7 subjects per group (D), and t test with n=3 replicates for E-F. * =p<0.05 for circadian rhythmicity or ChIP binding. Error bars = S.E.M.

Journal: Oncotarget

Article Title: The circadian clock regulates cisplatin-induced toxicity and tumor regression in melanoma mouse and human models

doi: 10.18632/oncotarget.24539

Figure Lengend Snippet: (A) Healthy human subjects were studied in-laboratory and subjected to 3 days of a simulated day shift schedule ( B , control condition) or a simulated night shift condition ( C , experimental condition). This was followed by a 24-hour constant routine protocol during which blood was drawn at 3-hour intervals (ZT2, ZT5, etc.) Blood samples collected at ZT2 and ZT14 (8 AM and 8 PM, respectively, in the day shift condition, or 8 PM and 8 AM in the night shift condition) were immediately treated with 10 μM cisplatin. Blood samples were incubated and fractions were collected between 2 and 24 hours later to isolate PBMCs. Genomic DNA was purified and probed for cisplatin-DNA adduct levels with an α-Pt-(GpG) antibody using a slot-blot assay. (D) mRNA was isolated from the blood samples and gene expression for XPA, the rate-limiting factor in NER, was analyzed using the NanoString multiplex assay. (E) DNA-protein interaction between the Bmal1 and XPA is shown in the first 3,000 base pair promoter region of human melanoma SKMEL-27 cells using a ChIP assay. PER2 is a circadian clock positive control. Input and IgG are experimental positive and negative controls, respectively. (F) Quantitation of Bmal1 binding to promoter regions of PER2 and XPA from ChIP assay, indicating regions of significance after IgG binding subtraction. Statistical analysis was done using two-way ANOVA with n=3 subjects per group (B-C) and cosinor analysis with n=7 subjects per group (D), and t test with n=3 replicates for E-F. * =p<0.05 for circadian rhythmicity or ChIP binding. Error bars = S.E.M.

Article Snippet: Oscillations of genes were analyzed using mixed-effects cosinor analysis (SAS software) [ ].

Techniques: Control, Incubation, Purification, Slot Blot Assay, Isolation, Gene Expression, Multiplex Assay, Positive Control, Quantitation Assay, Binding Assay